Metabolic approach to atherosclerosis: effect of gliclazide.
Brindley
D N
DN
Department of Biochemistry, University of Alberta, Edmonton, Canada.
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism*; D004195:Disease Models, Animal; D005907:Gliclazide / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000502:physiology; D007328:Insulin / Q000502:physiology; D012307:Risk Factors
D007328:Insulin; D005907:Gliclazide; D006854:Hydrocortisone